sintilimab Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (4)

Phase 1 (2)
Phase 2 (2)

Interventional (4)

Innovent Biologics (Suzhou) Co. Ltd. (2)
Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Xin-Hua Xu (1)

No (4)

No (4)

Adult (18+) (4)

I am/have/had

I am/have/hadinterstitial lung disease

I am/have/hadcarcinoma

I am/have/hadct scan

I am/have/hadunstable angina

I am/have/hadblood pregnancy test

I am/have/hadlung cancer

I am/have/hadgranulocyte colony stimulating factor

I am/have/hadstroke

I am/have/hadmyocardial infarction

I am/have/hadadjuvant therapy

I am/have/hadproteinuria

I am/have/hadcancer

I am/have/hadhepatocellular carcinoma

I am/have/hadtransient ischemic attack

I am/have/hadsystemic chemotherapy

I am/have/hadtuberculosis

I am/have/hadmeasurable disease

I am/have/hadhepatitis

I am/have/hadsmall cell lung cancer

I am/have/hadblood component

added new label for I am/have/had

I am looking for

I am looking forpaclitaxel

I am looking forcarboplatin

I am looking forpemetrexed

I am looking forgranulocyte colony stimulating factor

I am looking forapatinib

I am looking forcolony stimulating factor

I am looking forcapecitabine

I am looking forpd-1 inhibitor

I am looking forthyroid stimulating hormone

I am looking forsintilimab

I am looking forg-csf

added new label for I am looking for

Advanced Filters

Found 4 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC neoSCORE

This is a Phase 2, prospective, randomized, open-Label, single-center international study that assesses the efficacy and safety of neoadjuvant therapy with different cycles of sintilimab combined with chemotherapy for resectable NSCLC. This trial will also explore the biomarkers of neoadjuvant immunochemotherapy.

hepatitis

sintilimab

pemetrexed

small cell lung cancer

interstitial lung disease

0 views
05 Aug, 2020

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

The purpose of this study is to evaluate the safety and efficacy of Surufatinib plus Sintilimab in Patients with Advanced Solid Tumor

0 views
05 Aug, 2020

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Ib Study of the Efficacy and Safety of IBI310 Combined With Sintilimab in Advanced Hepatocellular Carcinoma

An open-label, single-arm, Ib study of the efficacy and safety of IBI310 combined with sintilimab in patients with advanced hepatocellular carcinoma

0 views
16 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma

This study aims to evaluate the efficacy and safety of Sintilimab (an Anti-PD-1 Inhibitor) combined with apatinib and capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.

measurable disease

hepatitis

blood component

ct scan

carcinoma

0 views
16 Feb, 2024
1 location